Giemsa-Wright staining displayed a lower frequency of immature blast cells in BM, together with less massive splenomegaly and significantly decreased leukemia infiltration in spleen and liver in secondary recipients of Fbxo22–/– AML cells (Fig. 3D–F). This evidence concerns the gene FBXO22 and leukemia.